CSIMarket
 


Astrotech Corp  (ASTC)
Other Ticker:  
 
 

ASTC's Net Income Growth by Quarter and Year

Astrotech's Net Income results by quarter and year




ASTC Net Income (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter June - -2.32 -2.02 -1.47
III Quarter March - -2.38 -2.10 -2.40
II Quarter December - -2.42 -2.18 -1.62
I Quarter September -2.91 -2.53 -2.03 -2.11
FY   -2.91 -9.65 -8.33 -7.60



ASTC Net Income first quarter 2024 Y/Y Growth Comment
Astrotech Corp in the first quarter 2024 recorded net loss of $ -2.91 millions.

According to the results reported in the first quarter 2024, Astrotech Corp achieved the best Net Income growth in Laboratory Analytical Instruments industry. While Astrotech Corp' s Net Income no change of % ranks overall at the positon no. in the first quarter 2024.




ASTC Net Income ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter June - - - -
III Quarter March - - - -
II Quarter December - - - -
I Quarter September - - - -
FY   - - - -

Financial Statements
Astrotech's first quarter 2024 Net Income $ -2.91 millions ASTC's Income Statement
Astrotech's first quarter 2023 Net Income $ -2.53 millions Quarterly ASTC's Income Statement
New: More ASTC's historic Net Income Growth >>


ASTC Net Income (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter June - - - -
III Quarter March - - - -
II Quarter December - - - -
I Quarter September - - - -
FY (Year on Year)   - - - -




Net Income first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Astrotech's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ASTC's I. Quarter Q/Q Net Income Comment
Current results of -2.91 millions by Astrotech Corp come out even worse if you take a look at -2.32 millions a quarter before.

Within Laboratory Analytical Instruments industry Astrotech Corp achieved highest sequential Net Income growth. While Astrotech's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ASTC's I. Quarter Q/Q Net Income Comment
I. Quarter 2024 net loss of -2.91 millions by Astrotech Corp come out even worse considering the net loss -2.32 millions in the previous quarter.

Within Laboratory Analytical Instruments industry Astrotech Corp achieved highest sequential Net Income growth. While Astrotech's Net Income growth quarter on quarter, overall rank is .


Astrotech's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Net Income 12 Months Ending $ -10.02 $ -9.64 $ -9.34 $ -9.07 $ -8.83
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Astrotech Corp' has realized cumulative trailing twelve months net loss of $ -10 millions in the Sep 30 2023 period.
The situation is getting worse as the cumulative net loss is becoming larger from $ -9.64 millions in the twelve months ending a quarter before and $ -8.33 millions for the twelve months ending in the quarter a year ago.

Astrotech Corp achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
Astrotech Corp' has realized cumulative trailing twelve months net loss of $ -10 millions in the Sep 30 2023 period.
The business is getting worse as the cumulative net loss is becoming larger from $ -9.64 millions in TTM ending quarter Jun 30 2023 and $ -8.33 millions for the twelve months ending in the quarter a year ago Natalie E. Jones wrote.

Astrotech Corp achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Laboratory Analytical Instruments Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
ASTC's Net Income Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for ASTC's Competitors
Net Income Growth for Astrotech's Suppliers
Net Income Growth for ASTC's Customers

You may also want to know
ASTC's Annual Growth Rates ASTC's Profitability Ratios ASTC's Asset Turnover Ratio ASTC's Dividend Growth
ASTC's Roe ASTC's Valuation Ratios ASTC's Financial Strength Ratios ASTC's Dividend Payout Ratio
ASTC's Roa ASTC's Inventory Turnover Ratio ASTC's Growth Rates ASTC's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2023
Gilead Sciences Inc 21.61%$ 21.613 millions
Neurocrine Biosciences Inc 21.31%$ 21.314 millions
Docgo Inc 20.50%$ 20.505 millions
Progyny Inc 20.34%$ 20.339 millions
Bristol myers Squibb Company20.27%$ 20.274 millions
Dexcom Inc 19.27%$ 19.269 millions
Idexx Laboratories Inc17.29%$ 17.295 millions
Biomx Inc 16.61%$ 16.608 millions
Ensign Group Inc13.74%$ 13.737 millions
Zoetis Inc 12.88%$ 12.879 millions
United Therapeutics Corporation11.83%$ 11.826 millions
Edwards Lifesciences Corporation11.70%$ 11.703 millions
Vertex Pharmaceuticals Inc11.26%$ 11.263 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com